ArticleJAAD case reports2018
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
Article in JAAD case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.Immunity, inflammation and disease · 2023Pooled it
- SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.International journal of dermatology · 2022Pooled it
- Article
- Pityriasis Rosea-Like Eruption following anti-fatigue traditional herbs: Aconitum carmichaelii Debx and Panax Ginseng suspected.BMC complementary medicine and therapies · 2024Article
- Pityriasis following COVID-19 vaccinations: a systematic review.Dermatology reports · 2024Article
- Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.Oman medical journal · 2023Article
- What's old is new: Valacyclovir for the treatment of pityriasis rosea, a retrospective case series.JAAD case reports · 2023Article
- Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.Dermatology reports · 2023Article
- Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.Dermatologic therapy · 2022Article
- The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.Dermatologic therapy · 2022Article
- Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.Journal of the Formosan Medical Association = Taiwan yi zhi · 2022Review
- Domperidone-induced pityriasis rosea-like drug eruption.Clinical case reports · 2022Article
- Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.Immunity, inflammation and disease · 2022Article
- Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Pityriasis rosea developing after COVID-19 vaccination.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.Dermatologic therapy · 2021Review
- Pityriasis rosea following SARS-CoV-2 vaccination: A case series.Journal of cosmetic dermatology · 2021Article
- Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.The British journal of dermatology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.